Global Pulmonary Function Testing Market
Taille du marché en milliards USD
TCAC :
% 
USD
3.88 Billion
USD
6.23 Billion
2024
2032
 Période de prévision |
2025 –2032 |
 Taille du marché (année de référence) |
USD 3.88 Billion |
 Taille du marché (année de prévision) |
USD 6.23 Billion |
 TCAC |
% |
| Principaux acteurs du marché |
|
Segmentation du marché mondial des tests de fonction pulmonaire, par type (matériel, services et logiciels), type de patient (pédiatrique, adulte et gériatrique), application (bronchopneumopathie obstructive et bronchite restrictive), utilisateur final (hôpitaux, cliniques spécialisées, laboratoires de diagnostic, établissements de soins à domicile et autres) - Tendances et prévisions du secteur jusqu'en 2032
Taille du marché des tests de la fonction pulmonaire
- La taille du marché mondial des tests de la fonction pulmonaire était évaluée à 3,88 milliards USD en 2024 et devrait atteindre 6,23 milliards USD d'ici 2032 , à un TCAC de 6,10 % au cours de la période de prévision.
- La croissance du marché est largement alimentée par l'adoption croissante et les progrès technologiques dans le domaine du diagnostic respiratoire et de la surveillance des patients, conduisant à une numérisation accrue dans les environnements cliniques et à domicile.
- De plus, la demande croissante des consommateurs pour des solutions précises, non invasives et intégrées d'évaluation de la fonction pulmonaire fait des tests de la fonction pulmonaire (TFP) un outil moderne de diagnostic et de surveillance de choix. Ces facteurs convergents accélèrent l'adoption de ces solutions, stimulant ainsi considérablement la croissance du secteur.
Analyse du marché des tests de la fonction pulmonaire
- Les appareils de test de la fonction pulmonaire (TFP), offrant une mesure précise du volume pulmonaire, de la capacité, des débits et des échanges gazeux, sont des composants de plus en plus essentiels des systèmes modernes de diagnostic respiratoire et de surveillance des patients, tant en milieu clinique qu'à domicile, en raison de leur précision accrue, de leur caractère non invasif et de leurs informations complètes sur la santé pulmonaire.
- La demande croissante d'appareils PFT est principalement alimentée par l'adoption généralisée de technologies de diagnostic avancées, la prévalence croissante des maladies respiratoires parmi les consommateurs et une préférence croissante pour la détection et la gestion précoces des maladies pulmonaires.
- L'Amérique du Nord domine le marché des tests de la fonction pulmonaire avec une part de marché de 38,9 %, caractérisée par une forte prévalence de maladies respiratoires, une infrastructure de soins de santé robuste et une forte présence d'acteurs clés de l'industrie.
- L'Asie-Pacifique devrait être la région connaissant la croissance la plus rapide sur le marché des tests de la fonction pulmonaire au cours de la période de prévision, avec un TCAC prévu de 7,7 %, en raison de l'urbanisation croissante, de l'augmentation des revenus disponibles et de l'amélioration des infrastructures de santé.
- Le segment des applications des maladies pulmonaires obstructives a dominé le marché des systèmes de test de la fonction pulmonaire en 2024 avec une part de marché de 39,8 %, en raison de la forte prévalence mondiale de la bronchopneumopathie chronique obstructive (BPCO) et de l'asthme et de la nécessité d'une surveillance et d'une gestion continues de ces maladies chroniques.
Portée du rapport et segmentation du marché des tests de la fonction pulmonaire
|
Attributs |
Principales informations sur le marché des tests de la fonction pulmonaire |
|
Segments couverts |
|
|
Pays couverts |
Amérique du Nord
Europe
Asie-Pacifique
Moyen-Orient et Afrique
Amérique du Sud
|
|
Acteurs clés du marché |
|
|
Opportunités de marché |
|
|
Ensembles d'informations de données à valeur ajoutée |
Outre les informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, une analyse des prix, une analyse de la part de marque, une enquête auprès des consommateurs, une analyse démographique, une analyse de la chaîne d'approvisionnement, une analyse de la chaîne de valeur, un aperçu des matières premières/consommables, des critères de sélection des fournisseurs, une analyse PESTLE, une analyse Porter et un cadre réglementaire. |
Tendances du marché des tests de la fonction pulmonaire
« Adoption croissante des appareils PFT portables et à domicile »
- Une tendance significative et croissante sur le marché mondial des tests de la fonction respiratoire est l'adoption croissante d'appareils d'EFR portables et à domicile, stimulée par la demande croissante de soins respiratoires décentralisés et centrés sur le patient. Cette évolution permet un accès plus large aux tests, notamment dans les régions reculées ou mal desservies, et s'inscrit dans l'accent mondial mis sur la télésanté et la prise en charge des maladies chroniques.
- Par exemple, des entreprises développent des spiromètres compacts et des appareils portables de mesure de la fonction respiratoire (EFR) qui se connectent à des smartphones ou des tablettes, permettant aux patients d'effectuer des tests précis de la fonction respiratoire depuis chez eux. Des appareils tels que le MIR Spirobank Smart et le NuvoAir Home Spirometer se sont révélés très faciles à utiliser et d'une précision comparable à celle des équipements de laboratoire, ce qui les rend adaptés au suivi régulier de maladies telles que la BPCO et l'asthme.
- Ces innovations sont particulièrement utiles pour la prise en charge des maladies respiratoires chroniques, car elles permettent un suivi continu de la fonction pulmonaire sans nécessiter de fréquentes consultations à l'hôpital. Les cliniciens peuvent accéder à distance aux données des patients via des plateformes cloud, identifier les premiers signes de détérioration et ajuster les plans de traitement en temps réel, améliorant ainsi l'observance et les résultats thérapeutiques des patients.
- L'intégration du Bluetooth et de la connectivité cloud dans les systèmes PFT portables améliore également le partage des données, l'interopérabilité avec les dossiers médicaux électroniques (DME) et prend en charge les analyses basées sur l'IA pour une prise de décision plus éclairée. Cela contribue à une approche plus dynamique et axée sur les données des soins respiratoires, tant en soins primaires que spécialisés.
- Alors que les systèmes de santé évoluent de plus en plus vers des modèles de soins axés sur la valeur et la prévention, la demande de solutions de tests pulmonaires portables et faciles d'utilisation s'accélère. Les fabricants réagissent en lançant des appareils et des écosystèmes logiciels mobiles qui prennent en charge le diagnostic à distance et la personnalisation des parcours de soins respiratoires.
Dynamique du marché des tests de la fonction pulmonaire
Conducteur
« Besoin croissant dû à la prévalence croissante des maladies respiratoires et aux progrès technologiques »
- La prévalence croissante des maladies respiratoires telles que la bronchopneumopathie chronique obstructive (BPCO), l'asthme et le cancer du poumon, associée aux progrès technologiques continus dans les dispositifs de diagnostic, est un facteur important de la demande accrue de solutions de tests de la fonction pulmonaire (TFP).
- Par exemple, en avril 2024, l'acquisition par Clario d'ArtiQ, une société d'interprétation des tests de fonction respiratoire (TFR) basée sur l'IA, enrichit son portefeuille de solutions respiratoires en intégrant des capacités d'IA avancées. Ces avancées stratégiques réalisées par des entreprises clés devraient stimuler la croissance du secteur des tests de fonction respiratoire au cours de la période de prévision.
- Alors que les prestataires de soins de santé et les patients sont de plus en plus conscients de l'importance d'un diagnostic précoce et d'une gestion efficace des affections pulmonaires, les appareils PFT offrent des fonctionnalités avancées pour une mesure précise des volumes pulmonaires, des capacités et du débit d'air, fournissant des informations cruciales pour le diagnostic et le traitement.
- De plus, la popularité croissante des appareils PFT portables et conviviaux, ainsi que le désir de capacités de surveillance à distance, font du PFT un élément essentiel des soins respiratoires modernes, offrant une intégration transparente avec les plateformes de santé numériques et les dossiers de santé électroniques.
- La commodité d'une évaluation précise et non invasive de la fonction pulmonaire dans divers contextes, notamment en milieu hospitalier, en clinique et à domicile, est un facteur clé de l'adoption de l'EFR. La tendance à la médecine personnalisée et la disponibilité croissante d'options EFR avancées contribuent également à la croissance du marché.
Retenue/Défi
« Préoccupations concernant les coûts initiaux élevés et le manque de professionnels qualifiés »
- Les inquiétudes concernant le coût initial élevé des systèmes avancés de tests de la fonction pulmonaire et la pénurie de professionnels qualifiés formés à la réalisation et à l’interprétation de ces tests constituent un défi important pour une pénétration plus large du marché.
- Par exemple, les spiromètres numériques et les systèmes de pléthysmographie avancés peuvent coûter entre 2 000 et 50 000 dollars américains , ce qui les rend inaccessibles aux petites cliniques et aux prestataires de soins de santé, notamment dans les régions à faible revenu et en développement. De plus, environ 35 % des établissements de santé des économies en développement sont confrontés à une pénurie de pneumologues qualifiés, ce qui limite l'adoption généralisée des systèmes de TFR.
- Pour favoriser une adoption plus large, il est essentiel de relever ces défis en matière de coût et d'expertise en développant des appareils EFR plus abordables et conviviaux, ainsi qu'en menant des actions de formation des professionnels de santé. Si les appareils EFR de base deviennent plus abordables, les fonctionnalités haut de gamme, telles que l'IA intégrée ou l'analyse avancée des échanges gazeux, sont souvent plus onéreuses.
- Bien que les prix diminuent progressivement, la prime perçue pour la technologie PFT avancée peut encore entraver l'adoption généralisée, en particulier pour ceux qui ne voient pas un besoin immédiat pour les fonctionnalités complètes offertes.
- Surmonter ces défis grâce à une meilleure accessibilité financière, à l'éducation des consommateurs sur les avantages d'un diagnostic précoce et au développement d'options PFT plus accessibles sera essentiel pour une croissance soutenue du marché.
Portée du marché des tests de la fonction pulmonaire
Le marché mondial des tests de la fonction pulmonaire est segmenté en fonction du type, du type de patient, de l'application et de l'utilisateur final.
- Par type
Le marché des tests de la fonction respiratoire est segmenté en fonction du type de produit : matériel, services et logiciels. Le segment du matériel détenait la plus grande part de marché en 2024, stimulé par le besoin essentiel d'appareils physiques tels que les spiromètres et les pléthysmographes pour réaliser des tests de la fonction respiratoire. L'innovation continue dans le domaine du matériel compact et portable contribue également à sa domination sur le marché.
Le segment des logiciels devrait enregistrer le TCAC le plus élevé, alimenté par l'intégration croissante de l'IA, de l'analyse de données et des solutions basées sur le cloud qui améliorent la fonctionnalité, l'interprétation et la gestion des données PFT.
- Par type de patient
Selon le type de patient, le marché des tests de la fonction respiratoire est segmenté en pédiatrie, en adulte et en gériatrie. Le segment adulte détient la plus grande part de marché, la prévalence de nombreuses maladies respiratoires chroniques augmentant significativement avec l'âge, ce qui entraîne un volume plus élevé d'examens de la fonction respiratoire (EFR) pratiqués sur des adultes.
Le segment gériatrique devrait connaître un TCAC important en raison du vieillissement de la population mondiale et de la plus grande vulnérabilité des personnes âgées à diverses affections respiratoires, ce qui stimulera la demande d'évaluations régulières de la fonction pulmonaire. Par exemple, sur le marché plus large des tests à domicile.
- Par application
En fonction des applications, le marché des tests de la fonction respiratoire est segmenté en maladies pulmonaires obstructives et maladies pulmonaires restrictives. Le segment des maladies pulmonaires obstructives, principalement porté par des pathologies telles que la bronchopneumopathie chronique obstructive (BPCO) et l'asthme, dominait le marché avec une part de marché estimée à 39,8 % en 2024. Cette domination s'explique par la forte prévalence mondiale de ces maladies chroniques et par le rôle crucial des tests de la fonction respiratoire dans leur diagnostic, leur évaluation de la gravité et leur prise en charge.
Le segment des maladies pulmonaires obstructives devrait connaître le taux de croissance le plus rapide entre 2025 et 2032. Cette croissance est principalement due à la prévalence croissante de la bronchopneumopathie chronique obstructive (BPCO), de l'asthme et d'autres affections obstructives, associée aux progrès des technologies de diagnostic.
- Par utilisateur final
En fonction de l'utilisateur final, le marché des tests de la fonction pulmonaire est segmenté entre hôpitaux, cliniques spécialisées, laboratoires de diagnostic, services de soins à domicile, etc. Le segment hospitalier représentait la plus grande part de chiffre d'affaires du marché, avec 50,7 % en 2024, grâce à ses capacités diagnostiques complètes, à son volume important de patients et à la disponibilité d'équipements de TFR de pointe. Les hôpitaux constituent les principaux centres de référence pour les cas respiratoires complexes.
Le segment des soins à domicile devrait connaître le taux de croissance le plus rapide, alimenté par la préférence croissante pour la surveillance à distance des patients, la commodité de la gestion des maladies chroniques et la disponibilité croissante d'appareils PFT portables adaptés à une utilisation à domicile.
Analyse régionale du marché des tests de la fonction pulmonaire
- L'Amérique du Nord domine le marché des tests de la fonction pulmonaire avec la plus grande part de marché, avec une part de marché de 38,9 % en 2024, grâce à une forte prévalence de maladies respiratoires, une infrastructure de soins de santé robuste et l'adoption précoce de technologies médicales avancées.
- Les consommateurs et les prestataires de soins de santé de la région apprécient grandement la précision, les capacités de diagnostic complètes et l'intégration transparente offertes par les systèmes PFT modernes avec d'autres solutions de santé numériques
- Cette adoption généralisée est en outre soutenue par des dépenses de santé élevées, une communauté médicale technologiquement avancée et une sensibilisation croissante au diagnostic précoce et aux soins de santé préventifs, faisant du PFT une solution privilégiée dans les hôpitaux, les cliniques et même les établissements de soins à domicile.
Aperçu du marché américain des tests de la fonction pulmonaire
Le marché américain des tests de la fonction respiratoire a représenté la plus grande part de chiffre d'affaires en 2024, avec 76,3 %. Cette croissance est alimentée par la prévalence croissante des maladies respiratoires, l'adoption croissante de technologies diagnostiques avancées et le développement des infrastructures de santé. Les consommateurs et les professionnels de santé accordent de plus en plus d'importance à l'amélioration de la surveillance de la santé respiratoire grâce à des systèmes de test intelligents, précis et accessibles. La préférence croissante pour les tests de la fonction respiratoire à domicile, combinée à une forte demande de surveillance à distance et d'intégration numérique, propulse davantage le secteur des tests de la fonction respiratoire. De plus, l'intégration croissante des technologies de santé numériques, telles que l'interprétation par l'IA et la gestion des données dans le cloud, contribue significativement à l'expansion du marché.
Aperçu du marché européen des tests de la fonction pulmonaire
Le marché européen des tests de la fonction respiratoire devrait connaître une croissance soutenue au cours de la période de prévision (2025-2032), principalement portée par la prévalence croissante des maladies respiratoires, les avancées technologiques et la demande croissante de médecine personnalisée. Le vieillissement de la population et la sensibilisation à la santé pulmonaire favorisent l'adoption des tests de la fonction respiratoire. Les consommateurs et les systèmes de santé européens sont également attirés par la précision et l'exhaustivité des informations offertes par ces appareils. La région connaît une croissance significative des applications en milieu hospitalier, en clinique spécialisée et à domicile, les tests de la fonction respiratoire étant intégrés aux protocoles de diagnostic établis et aux initiatives émergentes de télésanté.
Aperçu du marché britannique des tests de la fonction pulmonaire
Le marché britannique des tests de la fonction pulmonaire devrait connaître une croissance annuelle moyenne (TCAC) remarquable au cours de la période de prévision, portée par la prévalence croissante des maladies respiratoires et le souhait d'une précision et d'une praticité accrues des diagnostics. De plus, les préoccupations liées aux maladies pulmonaires chroniques et à la santé publique incitent les particuliers et les professionnels de santé à opter pour des solutions complètes d'évaluation de la fonction pulmonaire. L'adoption par le Royaume-Uni de dispositifs médicaux de pointe, conjuguée à la solidité de son infrastructure de santé, devrait continuer de stimuler la croissance du marché.
Analyse du marché allemand des tests de la fonction pulmonaire
Le marché allemand des tests de la fonction respiratoire devrait connaître une croissance annuelle moyenne (TCAC) considérable au cours de la période de prévision, stimulé par une sensibilisation croissante à la santé respiratoire et une demande croissante de solutions technologiquement avancées et précises. L'infrastructure bien développée de l'Allemagne, combinée à l'importance accordée à l'innovation et à des normes de santé élevées, favorise l'adoption des tests de la fonction respiratoire, notamment dans les hôpitaux et les laboratoires de diagnostic. L'intégration des tests de la fonction respiratoire aux systèmes de santé numériques se généralise également, avec une forte préférence pour des solutions de diagnostic sûres, fiables et de haute qualité, adaptées aux attentes des consommateurs et des cliniciens locaux.
Analyse du marché des tests de la fonction pulmonaire en Asie-Pacifique
Le marché des tests de la fonction pulmonaire en Asie-Pacifique devrait connaître une croissance annuelle composée (TCAC) record de 7,7 % entre 2025 et 2032 , portée par l'urbanisation croissante, la hausse des revenus disponibles et les avancées technologiques dans des pays comme la Chine, le Japon et l'Inde. La volonté croissante de la région d'améliorer les infrastructures de santé, soutenue par les initiatives gouvernementales en faveur de la santé publique, favorise l'adoption des tests de la fonction pulmonaire. De plus, l'émergence de la région Asie-Pacifique comme pôle de production de composants et de systèmes de tests de la fonction pulmonaire (TFP) permet à un public plus large de bénéficier d'un prix abordable et d'une accessibilité accrue.
Aperçu du marché japonais des tests de la fonction pulmonaire
Le marché japonais des tests de la fonction respiratoire prend de l'ampleur grâce à la culture high-tech du pays, à son urbanisation rapide et à la demande de soins de santé avancés. Le marché japonais accorde une importance particulière au diagnostic précoce et à la surveillance précise des affections respiratoires. L'adoption des tests de la fonction respiratoire est stimulée par le nombre croissant de patients atteints de maladies pulmonaires chroniques et par l'intégration des tests de la fonction respiratoire aux dossiers médicaux numériques. Le ministère de la Santé, du Travail et des Affaires sociales a indiqué que l'adoption des spiromètres numériques dans les hôpitaux japonais est passée de 45 % en 2021 à 72 % en 2023, avec des projections pour atteindre 85 % d'ici 2024. De plus, le vieillissement de la population japonaise devrait stimuler la demande de solutions de diagnostic plus faciles à utiliser et plus précises, tant en milieu clinique qu'à domicile.
Aperçu du marché indien des tests de la fonction pulmonaire
Le marché indien des tests de la fonction respiratoire devrait connaître son taux de croissance annuel composé le plus élevé, soit 7,8 % entre 2025 et 2032 , sous l'effet de la prévalence croissante des maladies respiratoires, de la hausse de la pollution atmosphérique et d'une sensibilisation croissante à la santé respiratoire. Le développement des infrastructures de santé du pays, conjugué aux initiatives gouvernementales de lutte contre les maladies respiratoires, favorise l'adoption croissante des solutions de tests de la fonction respiratoire. Le marché bénéficie également de la demande croissante d'outils de diagnostic portables et économiques, rendant les tests de la fonction respiratoire plus accessibles à une population plus large.
Part de marché des tests de la fonction pulmonaire
L’industrie des tests de la fonction pulmonaire est principalement dirigée par des entreprises bien établies, notamment :
- ZOLL Medical Corporation (États-Unis)
- Teleflex Incorporated (États-Unis)
- CAIRE, Inc. (États-Unis)
- COSMED srl (Italie)
- Schiller AG (Suisse)
- GANSHORN Medizin Electronic GmbH (Allemagne)
- PulmOne Advanced Medical Devices (Israël)
- ndd Medical Technologies (Suisse)
- KoKo PFT (Royaume-Uni)
- Geratherm Medical AG (Allemagne)
- ECO MEDICS AG (Suisse)
- Morgan Scientific (États-Unis)
- SIBEL, SAU (Espagne)
- Clarity Medical (Inde)
- Data Sciences International (États-Unis)
- IngMar Medical (États-Unis)
- Système médical JK (Inde)
- MEC COMPANY LTD (Royaume-Uni)
- Medline Industries, LP (États-Unis)
- Enregistreurs et systèmes d'assurance-maladie (Inde)
- VITALOGRAPH (Irlande)
- Medical Equipment Europe GmbH (Allemagne)
- CHEST MI, Inc. (Japon)
- CONTEC MEDICAL SYSTEMS CO., LTD (Chine)
- FUKUDA DENSHI (Japon)
Derniers développements sur le marché mondial des tests de la fonction pulmonaire
- En avril 2024, Clario, fournisseur leader de solutions pour les essais cliniques, a annoncé l'acquisition d'ArtiQ, une société d'interprétation des EFR basée sur l'IA. Cette opération stratégique vise à enrichir le portefeuille de solutions respiratoires de Clario en intégrant des fonctionnalités d'IA avancées, soulignant ainsi la tendance croissante à exploiter l'intelligence artificielle pour des analyses EFR plus précises et plus efficaces. Cette évolution témoigne de l'engagement du secteur à améliorer les capacités diagnostiques en soins respiratoires.
- En septembre 2023, PulmOne, développeur d'appareils portables de mesure de la fonction pulmonaire, a lancé le MiniBox+ en Chine. L'appareil a été présenté aux pneumologues lors du congrès annuel 2023 de la Société chinoise de thoracologie (CTS) par l'intermédiaire de son distributeur HTDK. Ce lancement témoigne de l'intérêt croissant pour les solutions de mesure de la fonction pulmonaire portables et accessibles, notamment sur des marchés en forte croissance comme la Chine, afin de répondre à la demande croissante de surveillance pratique de la fonction pulmonaire.
- En mai 2023, Vitalograph, leader reconnu du diagnostic respiratoire, a élargi sa gamme de produits avec le lancement de l'oscillomètre Vitalograph tremoflo C-100 lors de la conférence internationale de l'ATS. Ce nouvel appareil souligne l'évolution vers des méthodes de test avancées et non invasives, telles que l'oscillométrie, qui fournit des informations précises sur la fonction des petites voies aériennes sans nécessiter de manœuvres forcées, ce qui le rend idéal pour un plus large éventail de patients, y compris les enfants.
- En avril 2023, IngMar Medical, entreprise spécialisée dans les technologies de simulation respiratoire, a lancé la version 4.3 du logiciel RespiSim. Cette avancée majeure comprend une optimisation de l'importation/exportation de scénarios, une réduction du temps de latence de simulation et une stabilité accrue de la plateforme. Ces mises à jour améliorent considérablement la convivialité et les performances, faisant de ce logiciel un outil essentiel pour la formation en thérapie respiratoire, contribuant ainsi à une meilleure compréhension et application des principes de la PFT.
- En janvier 2023, CAIRE Inc. a acquis MGC Diagnostics Holdings, Inc., une opération stratégique visant à optimiser le vaste réseau de distribution mondial et l'empreinte industrielle de MGC. Cette acquisition améliore l'accès des patients aux systèmes de diagnostic cardiorespiratoire avancés de MGC, notamment les équipements EFR, et reflète la consolidation continue et les partenariats stratégiques sur le marché visant à élargir la portée et l'offre de produits.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL PULMONARY FUNCTION TESTING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
5 REGULATORY FRAMEWORK
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASING PREVALENCE OF RESPIRATORY DISEASES
6.1.2 EARLY DETECTION OF RESPIRATORY DISEASES
6.1.3 GROWING GERIATRIC POPULATION
6.1.4 INCREASING PRODUCT LAUNCHES AND EMERGENCE OF HOME TESTING DEVICES
6.2 RESTRAINTS
6.2.1 HIGH COST OF TESTING EQUIPMENT
6.2.2 TECHNOLOGICAL LIMITATION OF TESTING DEVICES
6.3 OPPORTUNITIES
6.3.1 RAPID TECHNOLOGICAL ADVANCEMENTS
6.3.2 RISING STRATEGIC INITIATIVES
6.3.3 GOVERNMENT INITIATIVES AND REIMBURSEMENT POLICIES
6.3.4 PRODUCT DEVELOPMENT FOR AT-HOME TESTING
6.4 CHALLENGES
6.4.1 LACK OF STANDARDIZATION AND VARIABILITY IN TEST RESULTS
6.4.2 LACK OF SKILLED PROFESSIONALS
7 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY TYPE
7.1 OVERVIEW
7.2 HARDWARE
7.2.1 PFT DEVICES
7.2.2 PFT ACCESSORIES & CONSUMABLES
7.2.2.1 SPIROMETRY
7.2.2.2 LUNG VOLUME IN UNIT/ PLETHYSMOGRAPHY TEST
7.2.2.3 GAS EXCHANGE TESTING
7.2.2.4 CARDIOPULMONARY EXERCISE TEST (CPET)
7.2.2.5 PULSE OXIMETRY TEST
7.2.2.6 DIFFUSION CAPACITY TEST
7.2.2.7 MAXIMAL VOLUNTARY VENTILATION
7.2.2.8 OXYGEN TITRATION TEST
7.2.2.9 RESPIRATORY MUSCLE FUNCTION
7.2.2.10 BRONCHIAL PROVOCATION TEST
7.2.2.11 HIGH ALTITUDE SIMULATION TESTING
7.2.3 OTHERS
7.2.3.1 3.2. DIRECT TENDER
7.2.3.2 3.2. RETAIL SALES
7.2.4 OTHERS
7.3 SOFTWARE
7.4 SERVICES
8 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE
8.1 OVERVIEW
8.2 ADULT
8.2.1 MALE
8.2.2 FEMALE
8.3 GERIATRIC
8.3.1 MALE
8.3.2 FEMALE
8.4 PEDIATRIC
8.4.1 MALE
8.4.2 FEMALE
9 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 OBSTRUCTIVE LUNG DISEASE
9.2.1 ASTHMA
9.2.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
9.2.3 BRONCHIECTASIS
9.2.4 CYSTIC FIBROSIS
9.3 RESTRICTIVE LUNG DISEASE
9.3.1 LUNG CANCER
9.3.2 INTERSTITIAL LUNG DISEASE
9.3.3 AMYOTROPHIC LATERAL SCLEROSIS (ALS)
9.3.4 SCOLIOSIS
9.3.5 SARCOIDOSIS
9.3.6 MUSCULAR DYSTROPHY
10 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.2.1 PUBLIC
10.2.2 PRIVATE
10.3 SPECIALTY CLINICS
10.4 DIAGNOSTICS LABORATORIES
10.5 HOME CARE SETTINGS
10.6 OTHERS
11 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 U.S.
11.2.2 CANADA
11.2.3 MEXICO
11.3 EUROPE
11.3.1 GERMANY
11.3.2 U.K.
11.3.3 FRANCE
11.3.4 FRANCE
11.3.5 ITALY
11.3.6 TURKEY
11.3.7 RUSSIA
11.3.8 SWITZERLAND
11.3.9 NETHERLANDS
11.3.10 SWEDEN
11.3.11 BELGIUM
11.3.12 DENMARK
11.3.13 NORWAY
11.3.14 FINLAND
11.3.15 POLAND
11.3.16 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 JAPAN
11.4.2 CHINA
11.4.3 SOUTH KOREA
11.4.4 INDIA
11.4.5 AUSTRALIA
11.4.6 SINGAPORE
11.4.7 TAIWAN
11.4.8 THAILAND
11.4.9 MALAYSIA
11.4.10 NEW ZEALAND
11.4.11 INDONESIA
11.4.12 VIETNAM
11.4.13 PHILIPPINES
11.4.14 REST OF ASIA-PACIFIC
11.5 MIDDLE EAST AND AFRICA
11.5.1 SOUTH AFRICA
11.5.2 SAUDI ARABIA
11.5.3 U.A.E.
11.5.4 ISRAEL
11.5.5 QATAR
11.5.6 KUWAIT
11.5.7 EGYPT
11.5.8 OMAN
11.5.9 BAHRAIN
11.5.10 REST OF MIDDLE EAST AND AFRICA
11.6 SOUTH AMERICA
11.6.1 BRAZIL
11.6.2 ARGENTINA
11.6.3 REST OF SOUTH AMERICA
12 GLOBAL PULMONARY FUNCTION TESTING MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: GLOBAL
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
12.3 COMPANY SHARE ANALYSIS: EUROPE
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
13 SWOT ANALYSIS
14 COMPANY PROFILES
14.1 VYAIRE MEDICAL, INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 COMPANY SHARE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 TELEFLEX INCORPORATED
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO 488
14.2.5 RECENT DEVELOPMENT 488
14.3 CAIRE INC.
14.3.1 COMPANY SNAPSHOT
14.3.2 COMPANY SHARE ANALYSIS
14.3.3 PRODUCT PORTFOLIO
14.3.4 RECENT DEVELOPMENTS
14.4 COSMED SRL
14.4.1 COMPANY SNAPSHOT
14.4.2 COMPANY SHARE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 SCHILLER AG
14.5.1 COMPANY SNAPSHOT
14.5.2 COMPANY SHARE ANALYSIS
14.5.3 PRODUCT PORTFOLIO
14.5.4 RECENT DEVELOPMENTS
14.6 CHEST M.I., INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENTS
14.7 CLARITY MEDICAL
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.8 CONTEC MEDICAL SYSTEMS CO., LTD
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENT
14.9 DATA SCIENCES INTERNATIONAL.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 ECO MEDICS
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 FUKUDA SANGYO CO., LTD.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 GANSHORN MEDIZIN ELECTRONIC GMBH
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 GERATHERM MEDICAL AG
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENT
14.14 INGMAR MEDICAL
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENT
14.15 INOFAB HEALTH (A CLARIO COMPANY)
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENT
14.16 JK MEDICAL SYSTEMS PVT LTD.
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 KOKO, PFT
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENTS
14.18 MEC
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENT
14.19 MEDICAL EQUIPMENT EUROPE GMBH
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENTS
14.2 MEDLINE
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENT
14.21 MORGAN SCIENTIFIC
14.21.1 COMPANY SNAPSHOT
14.21.2 PRODUCT PORTFOLIO
14.21.3 RECENT DEVELOPMENTS
14.22 NDD MEDICAL TECHNOLOGIES
14.22.1 COMPANY SNAPSHOT
14.22.2 PRODUCT PORTFOLIO
14.22.3 RECENT DEVELOPMENTS
14.23 PULMONE ADVANCED MEDICAL DEVICES
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENT
14.24 RECORDERS & MEDICARE SYSTEMS PRIVATE LIMITED
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENT
14.25 SCIREQ
14.25.1 COMPANY SNAPSHOT
14.25.2 PRODUCT PORTFOLIO
14.25.3 RECENT DEVELOPMENT
14.26 SIBEL, S.A.U
14.26.1 COMPANY SNAPSHOT
14.26.2 PRODUCT PORTFOLIO
14.26.3 RECENT DEVELOPMENT
14.27 VITALOGRAPH
14.27.1 COMPANY SNAPSHOT
14.27.2 PRODUCT PORTFOLIO
14.27.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
Liste des tableaux
TABLE 1 GLOBAL DRUG DELIVERY DEVICES MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 2 GLOBAL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 3 GLOBAL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 4 GLOBAL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 5 GLOBAL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (VOLUME IN UNIT)
TABLE 6 GLOBAL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 7 GLOBAL PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 8 GLOBAL PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (VOLUME IN UNIT)
TABLE 9 GLOBAL MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 10 GLOBAL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 11 GLOBAL NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 12 GLOBAL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 13 GLOBAL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 14 GLOBAL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 15 GLOBAL SOFTWARE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 16 GLOBAL SERVICES IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 17 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 18 GLOBAL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 19 GLOBAL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 20 GLOBAL GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 21 GLOBAL GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 22 GLOBAL PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 23 GLOBAL PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 24 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 25 GLOBAL OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 26 GLOBAL OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 27 GLOBAL RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 28 GLOBAL RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 29 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 30 GLOBAL HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 31 GLOBAL HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 32 GLOBAL SPECIALTY CLINICS IN PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 33 GLOBAL DIAGNOSTICS LABORATORIES IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 34 GLOBAL HOME CARE SETTINGS IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 35 GLOBAL OTHERS IN PULMONARY FUNCTION TESTING, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 36 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 37 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 38 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 39 NORTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 40 NORTH AMERICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 41 NORTH AMERICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 42 NORTH AMERICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 43 NORTH AMERICA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 44 NORTH AMERICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 45 NORTH AMERICA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 46 NORTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 47 NORTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 48 NORTH AMERICA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 49 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 50 NORTH AMERICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 51 NORTH AMERICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 52 NORTH AMERICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 53 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 54 NORTH AMERICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 55 NORTH AMERICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 56 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 57 NORTH AMERICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 58 U.S. PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 59 U.S. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 60 U.S. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 61 U.S. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 62 U.S. PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 63 U.S. MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 64 U.S. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 65 U.S. NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 66 U.S. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 67 U.S. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 68 U.S. RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 U.S. PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 70 U.S. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 71 U.S. GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 72 U.S. PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 73 U.S. PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 74 U.S. OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 75 U.S. RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 76 U.S. PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 77 U.S. HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 78 CANADA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 79 CANADA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 80 CANADA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 81 CANADA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 82 CANADA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 83 CANADA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 84 CANADA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 85 CANADA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 86 CANADA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 87 CANADA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 88 CANADA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 89 CANADA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 90 CANADA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 91 CANADA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 92 CANADA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 93 CANADA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 94 CANADA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 95 CANADA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 96 CANADA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 97 CANADA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 98 MEXICO PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 99 MEXICO HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 100 MEXICO PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 101 MEXICO PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 102 MEXICO PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 103 MEXICO MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 104 MEXICO ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 105 MEXICO NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 106 MEXICO HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 107 MEXICO HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 108 MEXICO RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 109 MEXICO PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 110 MEXICO ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 111 MEXICO GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 112 MEXICO PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 113 MEXICO PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 114 MEXICO OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 115 MEXICO RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 116 MEXICO PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 117 MEXICO HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 118 EUROPE PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 119 EUROPE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 120 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 121 EUROPE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 122 EUROPE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 123 EUROPE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 124 EUROPE MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 125 EUROPE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 126 EUROPE NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 127 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 128 EUROPE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 129 EUROPE RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 130 EUROPE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 131 EUROPE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 132 EUROPE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 133 EUROPE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 134 EUROPE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 135 EUROPE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 136 EUROPE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 137 EUROPE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 138 EUROPE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 139 GERMANY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 140 GERMANY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 141 GERMANY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 142 GERMANY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 143 GERMANY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 144 GERMANY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 145 GERMANY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 146 GERMANY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 147 GERMANY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 148 GERMANY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 149 GERMANY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 150 GERMANY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 151 GERMANY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 152 GERMANY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 153 GERMANY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 154 GERMANY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 155 GERMANY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 156 GERMANY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 157 GERMANY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 158 GERMANY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 159 U.K. PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 160 U.K. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 161 U.K. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 162 U.K. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 163 U.K. PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 164 U.K. MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 165 U.K. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 166 U.K. NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 167 U.K. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 168 U.K. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 169 U.K. RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 170 U.K. PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 171 U.K. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 172 U.K. GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 173 U.K. PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 174 U.K. PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 175 U.K. OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 176 U.K. RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 177 U.K. PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 178 U.K. HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 179 FRANCE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 180 FRANCE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 181 FRANCE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 182 FRANCE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 183 FRANCE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 184 FRANCE MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 185 FRANCE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 186 FRANCE NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 187 FRANCE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 188 FRANCE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 189 FRANCE RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 190 FRANCE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 191 FRANCE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 192 FRANCE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 193 FRANCE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 194 FRANCE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 195 FRANCE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 196 FRANCE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 197 FRANCE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 198 FRANCE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 199 SPAIN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 200 SPAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 201 SPAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 202 SPAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 203 SPAIN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 204 SPAIN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 205 SPAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 206 SPAIN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 207 SPAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 208 SPAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 209 SPAIN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 210 SPAIN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 211 SPAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 212 SPAIN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 213 SPAIN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 214 SPAIN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 215 SPAIN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 216 SPAIN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 217 SPAIN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 218 SPAIN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 219 ITALY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 220 ITALY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 221 ITALY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 222 ITALY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 223 ITALY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 224 ITALY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 225 ITALY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 226 ITALY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 227 ITALY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 228 ITALY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 229 ITALY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 230 ITALY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 231 ITALY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 232 ITALY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 233 ITALY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 234 ITALY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 235 ITALY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 236 ITALY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 237 ITALY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 238 ITALY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 239 TURKEY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 240 TURKEY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 241 TURKEY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 242 TURKEY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 243 TURKEY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 244 TURKEY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 245 TURKEY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 246 TURKEY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 247 TURKEY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 248 TURKEY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 249 TURKEY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 250 TURKEY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 251 TURKEY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 252 TURKEY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 253 TURKEY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 254 TURKEY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 255 TURKEY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 256 TURKEY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 257 TURKEY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 258 TURKEY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 259 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 260 RUSSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 261 RUSSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 262 RUSSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 263 RUSSIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 264 RUSSIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 265 RUSSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 266 RUSSIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 267 RUSSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 268 RUSSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 269 RUSSIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 270 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 271 RUSSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 272 RUSSIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 273 RUSSIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 274 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 275 RUSSIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 276 RUSSIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 277 RUSSIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 278 RUSSIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 279 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 280 SWITZERLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 281 SWITZERLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 282 SWITZERLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 283 SWITZERLAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 284 SWITZERLAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 285 SWITZERLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 286 SWITZERLAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 287 SWITZERLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 288 SWITZERLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 289 SWITZERLAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 290 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 291 SWITZERLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 292 SWITZERLAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 293 SWITZERLAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 294 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 295 SWITZERLAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 296 SWITZERLAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 297 SWITZERLAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 298 SWITZERLAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 299 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 300 NETHERLANDS HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 301 NETHERLANDS PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 302 NETHERLANDS PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 303 NETHERLANDS PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 304 NETHERLANDS MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 305 NETHERLANDS ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 306 NETHERLANDS NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 307 NETHERLANDS HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 308 NETHERLANDS HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 309 NETHERLANDS RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 310 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 311 NETHERLANDS ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 312 NETHERLANDS GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 313 NETHERLANDS PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 314 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 315 NETHERLANDS OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 316 NETHERLANDS RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 317 NETHERLANDS PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 318 NETHERLANDS HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 319 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 320 SWEDEN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 321 SWEDEN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 322 SWEDEN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 323 SWEDEN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 324 SWEDEN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 325 SWEDEN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 326 SWEDEN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 327 SWEDEN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 328 SWEDEN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 329 SWEDEN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 330 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 331 SWEDEN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 332 SWEDEN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 333 SWEDEN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 334 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 335 SWEDEN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 336 SWEDEN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 337 SWEDEN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 338 SWEDEN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 339 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 340 BELGIUM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 341 BELGIUM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 342 BELGIUM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 343 BELGIUM PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 344 BELGIUM MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 345 BELGIUM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 346 BELGIUM NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 347 BELGIUM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 348 BELGIUM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 349 BELGIUM RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 350 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 351 BELGIUM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 352 BELGIUM GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 353 BELGIUM PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 354 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 355 BELGIUM OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 356 BELGIUM RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 357 BELGIUM PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 358 BELGIUM HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 359 DENMARK PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 360 DENMARK HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 361 DENMARK PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 362 DENMARK PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 363 DENMARK PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 364 DENMARK MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 365 DENMARK ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 366 DENMARK NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 367 DENMARK HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 368 DENMARK HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 369 DENMARK RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 370 DENMARK PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 371 DENMARK ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 372 DENMARK GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 373 DENMARK PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 374 DENMARK PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 375 DENMARK OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 376 DENMARK RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 377 DENMARK PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 378 DENMARK HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 379 NORWAY PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 380 NORWAY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 381 NORWAY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 382 NORWAY PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 383 NORWAY PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 384 NORWAY MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 385 NORWAY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 386 NORWAY NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 387 NORWAY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 388 NORWAY HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 389 NORWAY RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 390 NORWAY PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 391 NORWAY ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 392 NORWAY GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 393 NORWAY PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 394 NORWAY PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 395 NORWAY OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 396 NORWAY RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 397 NORWAY PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 398 NORWAY HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 399 FINLAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 400 FINLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 401 FINLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 402 FINLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 403 FINLAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 404 FINLAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 405 FINLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 406 FINLAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 407 FINLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 408 FINLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 409 FINLAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 410 FINLAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 411 FINLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 412 FINLAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 413 FINLAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 414 FINLAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 415 FINLAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 416 FINLAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 417 FINLAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 418 FINLAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 419 POLAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 420 POLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 421 POLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 422 POLAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 423 POLAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 424 POLAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 425 POLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 426 POLAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 427 POLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 428 POLAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 429 POLAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 430 POLAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 431 POLAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 432 POLAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 433 POLAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 434 POLAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 435 POLAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 436 POLAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 437 POLAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 438 POLAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 439 REST OF EUROPE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 440 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 441 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 442 ASIA-PACIFIC HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 443 ASIA-PACIFIC PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 444 ASIA-PACIFIC PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 445 ASIA-PACIFIC PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 446 ASIA-PACIFIC MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 447 ASIA-PACIFIC ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 448 ASIA-PACIFIC NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 449 ASIA-PACIFIC HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 450 ASIA-PACIFIC HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 451 ASIA-PACIFIC RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 452 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 453 ASIA-PACIFIC ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 454 ASIA-PACIFIC GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 455 ASIA-PACIFIC PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 456 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 457 ASIA-PACIFIC OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 458 ASIA-PACIFIC RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 459 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 460 ASIA-PACIFIC HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 461 JAPAN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 462 JAPAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 463 JAPAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 464 JAPAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 465 JAPAN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 466 JAPAN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 467 JAPAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 468 JAPAN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 469 JAPAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 470 JAPAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 471 JAPAN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 472 JAPAN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 473 JAPAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 474 JAPAN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 475 JAPAN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 476 JAPAN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 477 JAPAN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 478 JAPAN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 479 JAPAN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 480 JAPAN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 481 CHINA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 482 CHINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 483 CHINA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 484 CHINA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 485 CHINA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 486 CHINA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 487 CHINA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 488 CHINA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 489 CHINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 490 CHINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 491 CHINA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 492 CHINA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 493 CHINA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 494 CHINA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 495 CHINA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 496 CHINA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 497 CHINA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 498 CHINA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 499 CHINA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 500 CHINA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 501 SOUTH KOREA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 502 SOUTH KOREA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 503 SOUTH KOREA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 504 SOUTH KOREA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 505 SOUTH KOREA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 506 SOUTH KOREA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 507 SOUTH KOREA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 508 SOUTH KOREA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 509 SOUTH KOREA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 510 SOUTH KOREA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 511 SOUTH KOREA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 512 SOUTH KOREA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 513 SOUTH KOREA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 514 SOUTH KOREA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 515 SOUTH KOREA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 516 SOUTH KOREA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 517 SOUTH KOREA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 518 SOUTH KOREA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 519 SOUTH KOREA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 520 SOUTH KOREA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 521 INDIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 522 INDIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 523 INDIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 524 INDIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 525 INDIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 526 INDIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 527 INDIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 528 INDIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 529 INDIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 530 INDIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 531 INDIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 532 INDIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 533 INDIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 534 INDIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 535 INDIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 536 INDIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 537 INDIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 538 INDIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 539 INDIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 540 INDIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 541 AUSTRALIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 542 AUSTRALIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 543 AUSTRALIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 544 AUSTRALIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 545 AUSTRALIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 546 AUSTRALIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 547 AUSTRALIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 548 AUSTRALIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 549 AUSTRALIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 550 AUSTRALIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 551 AUSTRALIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 552 AUSTRALIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 553 AUSTRALIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 554 USTRALIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 555 AUSTRALIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 556 AUSTRALIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 557 AUSTRALIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 558 AUSTRALIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 559 AUSTRALIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 560 AUSTRALIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 561 SINGAPORE PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 562 SINGAPORE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 563 SINGAPORE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 564 SINGAPORE PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 565 SINGAPORE PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 566 SINGAPORE MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 567 SINGAPORE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 568 SINGAPORE NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 569 SINGAPORE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 570 SINGAPORE HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 571 SINGAPORE RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 572 SINGAPORE PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 573 SINGAPORE ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 574 SINGAPORE GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 575 SINGAPORE PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 576 SINGAPORE PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 577 SINGAPORE OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 578 SINGAPORE RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 579 SINGAPORE PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 580 SINGAPORE HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 581 TAIWAN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 582 TAIWAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 583 TAIWAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 584 TAIWAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 585 TAIWAN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 586 TAIWAN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 587 TAIWAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 588 TAIWAN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 589 TAIWAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 590 TAIWAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 591 TAIWAN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 592 TAIWAN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 593 TAIWAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 594 TAIWAN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 595 TAIWAN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 596 TAIWAN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 597 TAIWAN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 598 TAIWAN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 599 TAIWAN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 600 TAIWAN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 601 THAILAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 602 THAILAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 603 THAILAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 604 THAILAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 605 THAILAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 606 THAILAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 607 THAILAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 608 THAILAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 609 THAILAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 610 THAILAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 611 THAILAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 612 THAILAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 613 THAILAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 614 THAILAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 615 THAILAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 616 THAILAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 617 THAILAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 618 THAILAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 619 THAILAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 620 THAILAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 621 MALAYSIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 622 MALAYSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 623 MALAYSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 624 MALAYSIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 625 MALAYSIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 626 MALAYSIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 627 MALAYSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 628 MALAYSIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 629 MALAYSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 630 MALAYSIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 631 MALAYSIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 632 MALAYSIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 633 MALAYSIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 634 MALAYSIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 635 MALAYSIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 636 MALAYSIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 637 MALAYSIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 638 MALAYSIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 639 MALAYSIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 640 MALAYSIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 641 NEW ZEALAND PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 642 NEW ZEALAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 643 NEW ZEALAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 644 NEW ZEALAND PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 645 NEW ZEALAND PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 646 NEW ZEALAND MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 647 NEW ZEALAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 648 NEW ZEALAND NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 649 NEW ZEALAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 650 NEW ZEALAND HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 651 NEW ZEALAND RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 652 NEW ZEALAND PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 653 NEW ZEALAND ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 654 NEW ZEALAND GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 655 NEW ZEALAND PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 656 NEW ZEALAND PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 657 NEW ZEALAND OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 658 NEW ZEALAND RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 659 NEW ZEALAND PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 660 NEW ZEALAND HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 661 INDONESIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 662 INDONESIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 663 INDONESIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 664 INDONESIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 665 INDONESIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 666 INDONESIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 667 INDONESIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 668 INDONESIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 669 INDONESIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 670 INDONESIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 671 INDONESIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 672 INDONESIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 673 INDONESIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 674 INDONESIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 675 INDONESIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 676 INDONESIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 677 INDONESIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 678 INDONESIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 679 INDONESIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 680 INDONESIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 681 VIETNAM PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 682 VIETNAM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 683 VIETNAM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 684 VIETNAM PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 685 VIETNAM PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 686 VIETNAM MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 687 VIETNAM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 688 VIETNAM NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 689 VIETNAM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 690 VIETNAM HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 691 VIETNAM RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 692 VIETNAM PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 693 VIETNAM ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 694 VIETNAM GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 695 VIETNAM PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 696 VIETNAM PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 697 VIETNAM OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 698 VIETNAM RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 699 VIETNAM PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 700 VIETNAM HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 701 PHILIPPINES PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 702 PHILIPPINES HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 703 PHILIPPINES PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 704 PHILIPPINES PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 705 PHILIPPINES PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 706 PHILIPPINES MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 707 PHILIPPINES ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 708 PHILIPPINES NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 709 PHILIPPINES HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 710 PHILIPPINES HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 711 PHILIPPINES RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 712 PHILIPPINES PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 713 PHILIPPINES ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 714 PHILIPPINES GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 715 PHILIPPINES PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 716 PHILIPPINES PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 717 PHILIPPINES OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 718 PHILIPPINES RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 719 PHILIPPINES PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 720 PHILIPPINES HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 721 REST OF ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 722 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 723 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 724 MIDDLE EAST AND AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 725 MIDDLE EAST AND AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 726 MIDDLE EAST AND AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 727 MIDDLE EAST AND AFRICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 728 MIDDLE EAST AND AFRICA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 729 MIDDLE EAST AND AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 730 MIDDLE EAST AND AFRICA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 731 MIDDLE EAST AND AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 732 MIDDLE EAST AND AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 733 MIDDLE EAST AND AFRICA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 734 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 735 MIDDLE EAST AND AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 736 MIDDLE EAST AND AFRICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 737 MIDDLE EAST AND AFRICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 738 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 739 MIDDLE EAST AND AFRICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 740 MIDDLE EAST AND AFRICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 741 MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 742 MIDDLE EAST AND AFRICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 743 SOUTH AFRICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 744 SOUTH AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 745 SOUTH AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 746 SOUTH AFRICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 747 SOUTH AFRICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 748 SOUTH AFRICA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 749 SOUTH AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 750 SOUTH AFRICA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 751 SOUTH AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 752 SOUTH AFRICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 753 SOUTH AFRICA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 754 SOUTH AFRICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 755 SOUTH AFRICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 756 SOUTH AFRICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 757 SOUTH AFRICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 758 SOUTH AFRICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 759 SOUTH AFRICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 760 SOUTH AFRICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 761 SOUTH AFRICA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 762 SOUTH AFRICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 763 SAUDI ARABIA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 764 SAUDI ARABIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 765 SAUDI ARABIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 766 SAUDI ARABIA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 767 SAUDI ARABIA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 768 SAUDI ARABIA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 769 SAUDI ARABIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 770 SAUDI ARABIA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 771 SAUDI ARABIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 772 SAUDI ARABIA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 773 SAUDI ARABIA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 774 SAUDI ARABIA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 775 SAUDI ARABIA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 776 SAUDI ARABIA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 777 SAUDI ARABIA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 778 SAUDI ARABIA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 779 SAUDI ARABIA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 780 SAUDI ARABIA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 781 SAUDI ARABIA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 782 SAUDI ARABIA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 783 U.A.E. PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 784 U.A.E. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 785 U.A.E. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 786 U.A.E. PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 787 U.A.E. PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 788 U.A.E. MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 789 U.A.E. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 790 U.A.E. NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 791 U.A.E. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 792 U.A.E. HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 793 U.A.E. RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 794 U.A.E. PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 795 U.A.E. ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 796 U.A.E. GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 797 U.A.E. PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 798 U.A.E. PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 799 U.A.E. OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 800 U.A.E. RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 801 U.A.E. PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 802 U.A.E. HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 803 ISRAEL PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 804 ISRAEL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 805 ISRAEL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 806 ISRAEL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 807 ISRAEL PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 808 ISRAEL MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 809 ISRAEL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 810 ISRAEL NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 811 ISRAEL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 812 ISRAEL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 813 ISRAEL RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 814 ISRAEL PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 815 ISRAEL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 816 ISRAEL GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 817 ISRAEL PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 818 ISRAEL PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 819 ISRAEL OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 820 ISRAEL RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 821 ISRAEL PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 822 ISRAEL HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 823 QATAR PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 824 QATAR HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 825 QATAR PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 826 QATAR PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 827 QATAR PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 828 QATAR MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 829 QATAR ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 830 QATAR NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 831 QATAR HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 832 QATAR HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 833 QATAR RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 834 QATAR PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 835 QATAR ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 836 QATAR GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 837 QATAR PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 838 QATAR PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 839 QATAR OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 840 QATAR RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 841 QATAR PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 842 QATAR HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 843 KUWAIT PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 844 KUWAIT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 845 KUWAIT PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 846 KUWAIT PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 847 KUWAIT PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 848 KUWAIT MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 849 KUWAIT ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 850 KUWAIT NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 851 KUWAIT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 852 KUWAIT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 853 KUWAIT RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 854 KUWAIT PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 855 KUWAIT ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 856 KUWAIT GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 857 KUWAIT PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 858 KUWAIT PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 859 KUWAIT OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 860 KUWAIT RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 861 KUWAIT PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 862 KUWAIT HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 863 EGYPT PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 864 EGYPT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 865 EGYPT PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 866 EGYPT PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 867 EGYPT PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 868 EGYPT MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 869 EGYPT ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 870 EGYPT NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 871 EGYPT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 872 EGYPT HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 873 EGYPT RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 874 EGYPT PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 875 EGYPT ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 876 EGYPT GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 877 EGYPT PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 878 EGYPT PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 879 EGYPT OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 880 EGYPT RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 881 EGYPT PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 882 EGYPT HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 883 OMAN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 884 OMAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 885 OMAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 886 OMAN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 887 OMAN PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 888 OMAN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 889 OMAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 890 OMAN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 891 OMAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 892 OMAN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 893 OMAN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 894 OMAN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 895 OMAN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 896 OMAN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 897 OMAN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 898 OMAN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 899 OMAN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 900 OMAN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 901 OMAN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 902 OMAN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 903 BAHRAIN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 904 BAHRAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 905 BAHRAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 906 BAHRAIN PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 907 BAHRAIN MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 908 BAHRAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 909 BAHRAIN NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 910 BAHRAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 911 BAHRAIN HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 912 BAHRAIN RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 913 BAHRAIN PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 914 BAHRAIN ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 915 BAHRAIN GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 916 BAHRAIN PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 917 BAHRAIN PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 918 BAHRAIN OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 919 BAHRAIN RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 920 BAHRAIN PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 921 BAHRAIN HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 922 REST OF MIDDLE EAST AND AFRICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 923 SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 924 SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 925 SOUTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 926 SOUTH AMERICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 927 SOUTH AMERICA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 928 SOUTH AMERICA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 929 SOUTH AMERICA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 930 SOUTH AMERICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 931 SOUTH AMERICA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 932 SOUTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 933 SOUTH AMERICA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 934 SOUTH AMERICA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 935 SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 936 SOUTH AMERICA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 937 SOUTH AMERICA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 938 SOUTH AMERICA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 939 SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 940 SOUTH AMERICA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 941 SOUTH AMERICA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 942 SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 943 SOUTH AMERICA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 944 BRAZIL PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 945 BRAZIL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 946 BRAZIL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 947 BRAZIL PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 948 BRAZIL PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 949 BRAZIL MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 950 BRAZIL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 951 BRAZIL NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 952 BRAZIL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 953 BRAZIL HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 954 BRAZIL RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 955 BRAZIL PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 956 BRAZIL ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 957 BRAZIL GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 958 BRAZIL PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 959 BRAZIL PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 960 BRAZIL OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 961 BRAZIL RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 962 BRAZIL PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 963 BRAZIL HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 964 ARGENTINA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 965 ARGENTINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 966 ARGENTINA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 967 ARGENTINA PFT DEVICES IN PULMONARY FUNCTION TESTING MARKET, BY MODALITY, 2022-2031 (USD THOUSAND)
TABLE 968 ARGENTINA PFT ACCESSORIES & CONSUMABLES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 969 ARGENTINA MOUTHPIECE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 970 ARGENTINA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY SIZE, 2022-2031 (USD THOUSAND)
TABLE 971 ARGENTINA NOSE CLIP IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 972 ARGENTINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY TEST TYPE, 2022-2031 (USD THOUSAND)
TABLE 973 ARGENTINA HARDWARE IN PULMONARY FUNCTION TESTING MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD THOUSAND)
TABLE 974 ARGENTINA RETAIL SALES IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 975 ARGENTINA PULMONARY FUNCTION TESTING MARKET, BY PATIENT TYPE, 2022-2031 (USD THOUSAND)
TABLE 976 ARGENTINA ADULT IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 977 ARGENTINA GERIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 978 ARGENTINA PEDIATRIC IN PULMONARY FUNCTION TESTING MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 979 ARGENTINA PULMONARY FUNCTION TESTING MARKET, BY APPLICATION, 2022-2031 (USD THOUSAND)
TABLE 980 ARGENTINA OBSTRUCTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 981 ARGENTINA RESTRICTIVE LUNG DISEASE IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 982 ARGENTINA PULMONARY FUNCTION TESTING MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 983 ARGENTINA HOSPITAL IN PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 984 REST OF SOUTH AMERICA PULMONARY FUNCTION TESTING MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
Liste des figures
FIGURE 1 GLOBAL PULMONARY FUNCTION TESTING MARKET: SEGMENTATION
FIGURE 2 GLOBAL PULMONARY FUNCTION TESTING MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL PULMONARY FUNCTION TESTING MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL PULMONARY FUNCTION TESTING MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL PULMONARY FUNCTION TESTING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL PULMONARY FUNCTION TESTING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL PULMONARY FUNCTION TESTING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 GLOBAL PULMONARY FUNCTION TESTING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL PULMONARY FUNCTION TESTING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL PULMONARY FUNCTION TESTING MARKET: SEGMENTATION
FIGURE 11 GLOBAL PULMONARY FUNCTION TESTING MARKET, BY TYPE
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 INCREASING PREVALENCE OF RESPIRATORY DISEASES IS DRIVING THE GROWTH OF THE GLOBAL PULMONARY FUNCTION TESTING MARKET FROM 2024 TO 2031
FIGURE 15 THE HARDWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PULMONARY FUNCTION TESTING MARKET IN 2024 AND 2031
FIGURE 16 DROC ANALYSIS
FIGURE 17 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY TYPE, 2023
FIGURE 18 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 19 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY TYPE, CAGR (2024-2031)
FIGURE 20 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY TYPE, LIFELINE CURVE
FIGURE 21 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, 2023
FIGURE 22 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 23 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, CAGR (2024-2031)
FIGURE 24 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY PATIENT TYPE, LIFELINE CURVE
FIGURE 25 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY APPLICATION 2023
FIGURE 26 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, 2024-2031 (USD THOUSAND)
FIGURE 27 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 28 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 29 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY END USER 2023
FIGURE 30 GLOBAL PULMONARY FUNCTION TESTING MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 31 GLOBAL PULMONARY FUNCTION TESTING MARKET: END USER, CAGR (2024-2031)
FIGURE 32 GLOBAL PULMONARY FUNCTION TESTING MARKET: END USER, LIFELINE CURVE
FIGURE 33 GLOBAL PULMONARY FUNCTION TESTING MARKET: SNAPSHOT (2023)
FIGURE 34 GLOBAL PULMONARY FUNCTION TESTING MARKET: COMPANY SHARE 2023 (%)
FIGURE 35 NORTH AMERICA PULMONARY FUNCTION TESTING MARKET: COMPANY SHARE 2023 (%)
FIGURE 36 EUROPE MEDICAL IMAGE MANAGEMENT MARKET: COMPANY SHARE 2023 (%)
FIGURE 37 ASIA-PACIFIC PULMONARY FUNCTION TESTING MARKET: COMPANY SHARE 2023 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
